Marubi(SH:603983) Xin Lang Cai Jing·2025-09-09 04:29Core Viewpoint - Marubi Biotechnology's stock price has experienced fluctuations, with a year-to-date increase of 26.26% and a recent decline in the last 20 and 60 days [1][2]. Group 1: Stock Performance - As of September 9, Marubi's stock price was 40.10 CNY per share, with a market capitalization of 16.08 billion CNY [1]. - The stock has seen a net outflow of 5.03 million CNY in principal funds, with large orders accounting for 5.91% of total buying and 16.63% of total selling [1]. - The company has appeared on the "Dragon and Tiger List" once this year, with the last appearance on August 25, where it recorded a net buy of -77.91 million CNY [1]. Group 2: Financial Performance - For the first half of 2025, Marubi achieved a revenue of 1.769 billion CNY, representing a year-on-year growth of 30.83%, and a net profit of 186 million CNY, up 5.21% year-on-year [2]. - Since its A-share listing, Marubi has distributed a total of 983 million CNY in dividends, with 610 million CNY distributed in the last three years [3]. Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders increased by 36.85% to 17,400, while the average circulating shares per person decreased by 26.93% to 23,084 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 1.4859 million shares, and several funds from the Fortune series that have reduced their holdings [3].